At a Glance
| Semax | Phosphatidylserine | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Nootropic, Neuroprotective |
| Routes | Intranasal | Oral |
| Effects | 0 documented | 7 documented |
Semax, a Nootropic, Neuroprotective, and Phosphatidylserine, a Nootropic, Neuroprotective, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Nootropic, Neuroprotectives, meaning they share a common pharmacological foundation. They share 0 documented effects in common, with 0 effects unique to Semax and 7 unique to Phosphatidylserine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Semax | Phosphatidylserine | |
|---|---|---|
| Class | Nootropic, Neuroprotective | Nootropic, Neuroprotective |
| Routes | Intranasal | Oral |
| Effects | 0 documented | 7 documented |
| Level | Dose |
|---|
| Threshold | 50 mcg |
| Light | 100–200 mcg |
| Common | 200–600 mcg |
| Strong | 600–900 mcg |
| Heavy | 1200 mcg |
| Level | Dose |
|---|---|
| Light | 100–200 mg |
| Common | 200–400 mg |
| Strong | 400–600 mg |
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.